Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2023 Mar;62(2):987-1001.
doi: 10.1007/s00394-022-03029-0. Epub 2022 Nov 8.

The effect of iron supplementation on maternal iron deficiency anemia does not differ by baseline anemia type among Tanzanian pregnant women without severe iron deficiency anemia

Affiliations
Clinical Trial

The effect of iron supplementation on maternal iron deficiency anemia does not differ by baseline anemia type among Tanzanian pregnant women without severe iron deficiency anemia

Ajibola Ibraheem Abioye et al. Eur J Nutr. 2023 Mar.

Abstract

Purpose: Whether anemia type modifies the risk of pregnancy and newborn outcomes and the effectiveness of iron supplementation is unclear. We examined the association of iron deficiency anemia (IDA) and non-iron deficiency anemia (NIDA) on the risks of these outcomes and the extent to which anemia type modifies the impact of prenatal iron supplementation.

Methods: This was a secondary analysis of a placebo-controlled trial of iron supplementation among 1450 HIV-negative women in Tanzania. Eligibility criteria included gestational age < 27 weeks, hemoglobin > 85 g/L, and ferritin > 12 µg/L. Individuals were categorized as non-anemia, IDA or NIDA using hemoglobin, ferritin and CRP. Analyses were conducted using regression models and likelihood ratio tests.

Results: Compared to the non-anemia group, delivery hemoglobin was lower by 15 g/L (95% CI 10.9, 19.3) in the baseline IDA group, and 7.3 g/L (95% CI 3.1, 11.5) in the baseline NIDA group. The RRs of anemia severity, iron deficiency, placental malaria, stillbirths, perinatal mortality, birthweight, and preterm birth were not different among women in the baseline NIDA group (vs. non-anemia) compared to the baseline IDA group (vs. non-anemia). The difference in the mean delivery hemoglobin for iron supplementation and placebo arms was 8 g/L (95% CI 6, 11) in the non-anemia group, 7 g/L (95% CI 2, 13) in the NIDA group, and 16 g/L (95% CI 10, 22) in the IDA group.

Conclusion: Iron supplementation is effective even among pregnant women with NIDA.

Trial registration: NCT01119612 (May 7, 2010).

Keywords: Anemia; Inflammation; Iron; Iron deficiency; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

Declarations

Conflict of interest None of the authors have any conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart of participant selection

Similar articles

Cited by

References

    1. Gardner W, Kassebaum N (2020) Global, regional, and national prevalence of anemia and its causes in 204 countries and territories, 1990–2019. Curr Develop Nutr 4(2):830–830
    1. Weze K, Abioye AI, Obiajunwa C, Omotayo M (2021) Spatio-temporal trends in anemia among pregnant women, adolescents and preschool children in sub-Saharan Africa. Public Health Nutrition 24(12):3648–3661 - PMC - PubMed
    1. Msuya SE, Hussein TH, Uriyo J, Sam NE, Stray-Pedersen B (2011) Anaemia among pregnant women in northern Tanzania: prevalence, risk factors and effect on perinatal outcomes. Tanzan J Health Res 13(1):33–39 - PubMed
    1. Petry N, Olofin I, Hurrell RF, Boy E, Wirth JP, Moursi M, Donahue Angel M, Rohner F (2016) The Proportion of anemia associted with iron deficiency in low, medium, and high human development index countries: a systematic analysis of national surveys. Nutrients. 10.3390/nu8110693 - DOI - PMC - PubMed
    1. Shaw JG (2011) Friedman JF Iron deficiency anemia: focus on infectious diseases in lesser developed countries. Anemia 260380:1–10 - PMC - PubMed

Publication types

Associated data